Detalhe da pesquisa
1.
Standardized Computer-Assisted Analysis of PRAME Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas.
Int J Mol Sci
; 24(7)2023 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37047361
2.
Checkpoint-inhibitor induced Polyserositis with Edema.
Cancer Immunol Immunother
; 71(12): 3087-3092, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35576074
3.
Ultraviolet Filters: Dissecting Current Facts and Myths.
J Clin Med
; 13(10)2024 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38792526
4.
Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors.
Eur J Cancer
; 203: 114028, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652976
5.
The side effect registry immuno-oncology (SERIO) - A tool for systematic analysis of immunotherapy-induced side effects.
Eur J Cancer
; 199: 113505, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262306
6.
Characterization of the impact of immune checkpoint inhibitors on platelet activation and aggregation.
Immunobiology
; 228(1): 152311, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495598
7.
Conventional and three-dimensional photography as a tool to map distribution patterns of in-transit melanoma metastases on the lower extremity.
Front Med (Lausanne)
; 10: 1089013, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36744147
8.
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors.
Med
; 4(2): 113-129.e7, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693381
9.
Hematological immune related adverse events after treatment with immune checkpoint inhibitors.
Eur J Cancer
; 147: 170-181, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33706206
10.
Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition - A Descriptive Observational Retrospective Multicenter Analysis.
Front Oncol
; 11: 765608, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34746007
11.
Response to letter entitled: 'Re: Hematological immune related adverse events after treatment with immune checkpoint inhibitors'.
Eur J Cancer
; 153: 272-273, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34154880